Regulatory updates on COVID-19:
Interim Guidance on Blood Supply:
The Coronavirus Explained & What You Should Do:
Technical Guidance: Infection Prevention and Control
Situation Reports and Dashboard:
How to Use Masks:
Q&A on smoking and COVID-19:
Q&A on COVID-19, pregnancy, childbirth and breastfeeding:
Advice on the use of masks in the community, during home care and in healthcare settings in the context of the novel coronavirus (COVID-19) outbreak:
The Food and Drug Administration (FDA) has issued updated information for blood establishments regarding the ongoing coronavirus disease 2019 (COVID-19) pandemic and blood donations.
To date, there have been no reported cases of transfusion-transmitted coronavirus, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The FDA does not recommend using COVID-19 laboratory tests to screen routine blood donors.
The European Commission’s top priorities are safeguarding the health and well-being of our citizens and using all of the tools at its disposal.
This is why it is taking all necessary steps to coordinate with Member States and to facilitate the supply of protective and medical equipment across Europe.
The correct treatment and management of patients with red blood cells disorders may be challenging, given the rapid spread of the pandemia and lack of literature so far.
At this crucial stage, efforts are being devoted by different initiatives for the generation of indications, all gathered in one page by EuroBloodNet.
This highly acclaimed series continues to explore the different topics and challenges that healthcare workers, leaders and the public are facing, and how we are responding.
Developed to support and unite all healthcare workers on the frontlines with senior decision makers leading the response in this critical fight against COVID-19, as we navigate the challenges presented by the pandemic.